IL6 and metabolic syndrome: In fact, inflammatory cytokines like IL-6 were shown to link with dyslipidemia by promoting de novo hepatic fatty acid synthesis and suppressing the activity of lipoprotein lipase, a key enzyme involving in catabolism of triglyceride-rich lipoproteins [41].